Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2021-03-16
- Lead Sponsor
- Mallinckrodt ARD LLC
- Target Recruit Count
- 44
- Registration Number
- NCT03400852
- Locations
- 🇺🇸
NW FL Clinical Research Group, LLC, Gulf Breeze, Florida, United States
🇺🇸Rare Disease Research, LLC, Atlanta, Georgia, United States
🇺🇸Monroe Carell Jr Childrens Hospital at Vanderbilt, Nashville, Tennessee, United States
Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2021-07-12
- Lead Sponsor
- Mallinckrodt ARD LLC
- Target Recruit Count
- 35
- Registration Number
- NCT03126760
- Locations
- 🇺🇸
Stanford University Medical Center, Palo Alto, California, United States
🇺🇸Advanced Neurosciences Research LLC, Fort Collins, Colorado, United States
🇺🇸University of South Florida, Bradenton, Florida, United States
Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria
- Conditions
- Idiopathic Focal Segmental Glomerulosclerosis
- Interventions
- First Posted Date
- 2015-12-17
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Mallinckrodt ARD LLC
- Target Recruit Count
- 63
- Registration Number
- NCT02633046
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸AKDHC Medical Research Services, LLC, Tucson, Arizona, United States
🇺🇸California Institute of Renal Research, Chula Vista, California, United States